Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

FIRMAGON

DEGARELIX ACETATE

Standard Dose
EQ 80MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview FIRMAGON is listed in Drugs@FDA under application 022201 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient DEGARELIX ACETATE Form and strength POWDER;SUBCUTANEOUS - EQ 80MG BASE/VIAL Sponsor FERRING Submission history Latest submission status date: 2020-02-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview FIRMAGON is listed in Drugs@FDA under application 022201 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DEGARELIX ACETATE Form and strength POWDER;SUBCUTANEOUS - EQ 80MG BASE/VIAL Sponsor FERRING Submission history Latest submission status date: 2020-02-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.